Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830940) titled 'Finerenone and Cardiac Remodeling in HFpEF' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Assiut University

Condition: Heart Failure With Preserved Ejection Fraction

Intervention: Drug: Finerenone

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 20, 2026

Target Sample Size: 194

To know more, visit https://clinicaltrials.gov/study/NCT07830940

Published by HT Digital Content Services with permission from Health Daily Diges...